Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,763
Total Claims
$1.6M
Drug Cost
313
Beneficiaries
$5,224
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 5,101 Rheumatology providers
-56%
Opioid rate vs peers
1.8% vs 4.1% avg
-13%
Cost per patient vs peers
$5,224 vs $6,039 avg
Opioid Prescribing
1.8%
Opioid Rate
49
Opioid Claims
$165
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 2,417 claims · $61K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Adalimumab | 58 | $436K |
| Adalimumab | 47 | $352K |
| Certolizumab Pegol | 24 | $140K |
| Teriparatide | 31 | $130K |
| Sarilumab | 25 | $110K |
| Etanercept | 14 | $106K |
| Milnacipran Hcl | 17 | $14K |
| Hydroxychloroquine Sulfate | 307 | $13K |
| Leflunomide | 188 | $8,973 |
| Colchicine | 46 | $8,839 |
| Duloxetine Hcl | 240 | $5,282 |
| Methotrexate Sodium | 202 | $5,180 |
| Colchicine | 17 | $5,103 |
| Febuxostat | 29 | $3,208 |
| Gabapentin | 326 | $2,939 |
Prescribing Profile
Patient Profile
70
Avg Age
85%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About